Novo Ventures is ready for steady deployment of funds amid IPO lull
Novo Ventures senior partner, Naveed Siddiqi, discussed the opportunity in a slumbering IPO market to raise larger funding rounds, in an interview with Unquote.
Novo Ventures senior partner, Naveed Siddiqi, discussed the opportunity in a slumbering IPO market to raise larger funding rounds, in an interview with Unquote.
LONDON, 29 October 2021: Arix Bioscience plc (LSE: ARIX, “Arix”), a global venture capital company focused on investing in and building breakthrough biotech companies, today notes that its portfolio company, Aura Biosciences, Inc., (“Aura”), has announced the pricing of its initial public offering of 5,400,000 shares of common stock at a public offering price of […]